异常蛋白血症与肾脏:2019核心教程
本文综述了异常蛋白血症相关肾病的发病机制、诊断与治疗。B细胞或浆细胞克隆产生致病性单克隆免疫球蛋白或轻链导致肾损伤,临床表现从亚肾病范围蛋白尿到严重急性肾损伤不等。治疗目标是根除克隆实现血液学反应,器官特异性反应依赖于此;未治疗者进展性肾病和终末期肾病风险高。
要点
- 单克隆免疫球蛋白可致多种病理类型,包括管型肾病、沉积病、淀粉样变和炎性肾小球肾炎。
- 小克隆B细胞或浆细胞群所致的肾脏病变归类为具有肾脏意义的单克隆丙种球蛋白病。
- 治疗目标是根除克隆实现血液学反应,器官反应依赖血液学反应。
核心结论
- 异常蛋白血症肾病由B细胞或浆细胞克隆产生的致病性单克隆免疫球蛋白或轻链引起,治疗目标是根除克隆实现血液学反应。
研究设计与样本
- 本文为AJKD肾脏病学核心教程综述,回顾异常蛋白血症肾病的发病机制、诊断和治疗。
主要发现
- 临床表现可从亚肾病范围蛋白尿或镜下血尿伴肾功能保留,到严重肾病综合征,再到严重急性肾损伤或快速进展性肾小球肾炎。
- 单克隆免疫球蛋白可引起多种组织学损伤模式,包括管型肾病、肾小球和肾小管沉积病、淀粉样变性和炎性肾小球肾炎。
- 部分患者 underlying 克隆性疾病符合显性多发性骨髓瘤或系统性淋巴瘤标准,小克隆群者归类为具有肾脏意义的单克隆丙种球蛋白病。
关键数值与推荐
- 器官特异性反应依赖于实现血液学反应(即单克隆蛋白改善或消失)。
- 未适当治疗时,许多此类疾病与进展性肾病和终末期肾病高风险相关。
临床怎么用
- 对异常蛋白血症肾病患者,治疗应针对根除 underlying 克隆以实现血液学反应,从而获得器官反应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Dysproteinemic kidney diseases occur when B- or plasma cell clones produce pathogenic monoclonal immunoglobulins or light chains that cause kidney damage. The clinical presentation of these disorders ranges from sub-nephrotic-range proteinuria or microscopic hematuria with preserved kidney function to severe nephrotic syndrome to severe acute kidney injury or rapidly progressive glomerulonephritis. These monoclonal immunoglobulins can cause a variety of histologic patterns of injury, including cast nephropathy, glomerular and tubular deposition diseases, amyloidosis, and inflammatory glomerulonephritis. The underlying clonal disorder may meet criteria for overt multiple myeloma or systemic lymphoma. In recent years, there has been increased recognition and study of dysproteinemic kidney diseases that occur in the setting of smaller clonal plasma and B-cell populations, which are classified as monoclonal gammopathies of renal significance. Regardless of clonal cell burden, the goal of treatment is to achieve a hematologic response (ie, improvement or resolution of the monoclonal protein) by eradicating the underlying clone. Organ-specific responses are dependent on achieving hematologic response. Without appropriate treatment, many of these disorders are associated with high rates of progressive kidney disease and end-stage kidney disease. In this installment of AJKD's Core Curriculum in Nephrology, we review the pathogenesis, diagnosis, and treatment of dysproteinemic kidney diseases.
引用
- Hogan JJ, Alexander MP, Leung N, et al. Dysproteinemia and the Kidney: Core Curriculum 2019. Am J Kidney Dis. 2019. PMID: 31331759. doi:10.1053/j.ajkd.2019.04.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。